Lisa Christopher-Stine Selected Research

Contraception (Birth Control)

1/2020	2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
1/2020	2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa Christopher-Stine Research Topics

Disease

56	Myositis (Idiopathic Inflammatory Myopathies) 05/2024 - 06/2009
32	Dermatomyositis (Dermatopolymyositis) 05/2024 - 06/2004
28	Muscular Diseases (Myopathy) 04/2024 - 11/2006
12	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2023 - 06/2009
11	Neoplasms (Cancer) 10/2023 - 11/2013
10	Inclusion Body Myositis 02/2023 - 11/2014
7	Musculoskeletal Diseases (Musculoskeletal Disease) 04/2022 - 01/2020
6	Inflammation (Inflammations) 05/2024 - 06/2004
6	Polymyositis 05/2024 - 06/2004
6	Muscle Weakness 03/2023 - 06/2010
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2023 - 01/2016
6	Antisynthetase syndrome 02/2023 - 06/2009
6	COVID-19 01/2023 - 10/2020
6	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 06/2015
5	Myotoxicity 11/2017 - 11/2006
4	Connective Tissue Diseases (Connective Tissue Disease) 11/2019 - 06/2009
3	Rheumatoid Arthritis 02/2023 - 08/2013
3	Rheumatic Diseases (Rheumatism) 01/2023 - 06/2016
3	Myocarditis (Carditis) 01/2023 - 12/2014
3	Melanoma (Melanoma, Malignant) 12/2022 - 08/2013
3	Deglutition Disorders (Dysphagia) 01/2022 - 11/2017
3	Myalgia 11/2017 - 06/2010
3	Lupus Nephritis 12/2015 - 06/2004
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 10/2019
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 04/2024 - 01/2019
2	Amyopathic dermatomyositis 03/2024 - 12/2021
2	Calcinosis 11/2021 - 11/2017
2	Exanthema (Rash) 05/2021 - 12/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Rhabdomyolysis 01/2019 - 11/2006
2	Heart Diseases (Heart Disease) 01/2019 - 01/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 04/2017 - 09/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 08/2015
2	Limb-girdle muscular dystrophy type 2A 01/2017 - 12/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 12/2010
2	Arthritis (Polyarthritis) 08/2013 - 06/2009
2	Proteinuria 01/2008 - 08/2004
1	Skin Diseases (Skin Disease) 03/2023
1	Lung Diseases (Lung Disease) 03/2023
1	Sjogren's Syndrome (Sjogren Syndrome) 02/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Pneumothorax 01/2023
1	Mediastinal Emphysema (Pneumomediastinum) 01/2023

Drug/Important Bio-Agent (IBA)

49	AutoantibodiesIBA 03/2024 - 06/2009
21	AntibodiesIBA 05/2024 - 09/2010
16	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 11/2006
15	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 03/2011
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2004
9	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 06/2010
8	EnzymesIBA 01/2023 - 03/2011
7	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
6	AutoantigensIBA 01/2024 - 12/2009
6	Coenzyme A (CoA)IBA 01/2023 - 08/2012
4	ImmunosorbentsIBA 01/2023 - 03/2011
4	tofacitinibIBA 01/2022 - 01/2017
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
4	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2021 - 03/2011
3	GlucocorticoidsIBA 11/2022 - 02/2021
3	Immunoglobulin M (IgM)IBA 05/2022 - 10/2020
3	Signal Recognition ParticleIBA 01/2022 - 09/2010
3	InterferonsIBA 11/2021 - 01/2019
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 08/2004
2	Janus Kinase InhibitorsIBA 03/2023 - 01/2021
2	Mi-2 antibodiesIBA 01/2023 - 01/2022
2	IFIH1 Interferon-Induced HelicaseIBA 01/2023 - 08/2013
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	Methylprednisolone FDA LinkGeneric 01/2023 - 05/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2022
2	UbiquitinIBA 01/2023 - 05/2021
2	AngiotensinsIBA 05/2022 - 10/2020
2	transcriptional intermediary factor 1IBA 01/2022 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2012
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 11/2019
2	LipidsIBA 01/2021 - 05/2015
2	Antiphospholipid AntibodiesIBA 01/2020 - 01/2020
2	Azathioprine (Imuran)FDA LinkGeneric 11/2019 - 09/2019
2	SS-A antibodiesIBA 01/2019 - 12/2015
2	CholesterolIBA 11/2017 - 12/2014
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017 - 08/2015
2	CreatinineIBA 01/2008 - 08/2004
1	Immunoglobulins (Immunoglobulin)IBA 01/2024
1	Nuclear RNAIBA 01/2024
1	Sp4 Transcription FactorIBA 02/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	tixagevimabIBA 01/2023
1	nuclear matrix protein 2IBA 01/2023
1	Interferon Type IIBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	sperm releasing substanceIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	cilgavimabIBA 01/2023
1	Hydroxyl RadicalIBA 05/2022
1	mRNA VaccinesIBA 04/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	imidazole mustard (BIC)IBA 01/2022

Therapy/Procedure

14	Therapeutics 11/2021 - 06/2004
2	Immunomodulation 05/2022 - 01/2022
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020 - 01/2020
2	Contraception (Birth Control) 01/2020 - 01/2020